Get notified of page updates
Enroll in Research > Research Search & Enroll Tool > Adding Pembrolizumab to Olaparib to Treat Pancreatic Cancer in People with an Inherited BRCA Mutation
Adding Pembrolizumab to Olaparib to Treat Pancreatic Cancer in People with an Inherited BRCA Mutation

Adding Pembrolizumab to Olaparib to Treat Pancreatic Cancer in People with an Inherited BRCA Mutation

Clinicaltrials.gov identifier:
NCT04548752

Treatment
Metastatic pancreatic cancer and a BRCA1 or BRCA2 mutation

Study Contact Information:

Principal Investigator: Vincent Chung by email           
Southwest Oncology Group


Adding Pembrolizumab to Olaparib to Treat Pancreatic Cancer in People with an Inherited BRCA Mutation

About the Study

This study is researching whether adding the  drug Pembrolizumab (Keytruda) to the  Olaparib (Lynparza) works better than olaparib alone in treating people with pancreatic cancer who also have an inherited or mutation.  

Type of Study

This is a , open label, two-arm study.

  • The study is divided into two separate treatment groups: one group will receive olaparib alone, the other group will receive both olaparib and pembrolizumab. 
  • This is a study, which means that people will not choose which treatment they receive, but will be selected by chance to be one of the treatment groups. Neither patients in the study nor the doctor will get to decide which group participants are placed in.
  • The study is open label, which means that once they are placed in a group, participants will know which group they are in and which drugs they will receive. 

What the Study Entails:

Both groups:

  • Patients in both Group 1 and Group 2 will receive olaparib orally twice per day on days 1-21. Cycles repeat every 21 days as long as the participant doesn't have serious side effects. 
  • Patients are followed for up to 3 years.

Group 1

  • Patients in Group 1 will also receive Pembrolizumab intravenous (IV) over 30 minutes on day 1 of each cycle for up to 18 cycles as long as the.participant doesn't experience serious side effects. 
  • Beginning with cycle 19, patients will receive Olaparib orally twice per day on days 1-42 and continue with Pembrolizumab IV over 30 minutes on day 1 of each cycle. These cycles repeat every 42 days in the absence of disease progression or unacceptable .

Study Sites:

There are over 280 (Recruiting) study sites across the U.S. Check out the listing on clinicaltrials.gov or on the Southwest Oncology Group (SWOG) site for specific study sites and contacts. 

  • Arizona
  • Arkansas
  • California
  • Colorado
  • Connecticut
  • Florida
  • Idaho
  • Illinois
  • Indiana
  • Iowa
  • Kentucky
  • Michigan
  • Minnesota
  • Missouri
  • Montana
  • Nebraska
  • North Carolina
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Texas
  • Washington
  • Wisconsin
  • Wyoming

Arizona

  •  Phoenix, Arizona
    Cancer Center at Saint Joseph's     
    Contact: Site Public Contact    602-406-8222     
    Principal Investigator: Richard L. Deming        

Arkansas

  • Fort Smith, Arkansas
    Mercy Hospital Fort Smith   
    Contact: Site Public Contact    800-378-9373     
    Principal Investigator: Jay W. Carlson        
  • Hot Springs, Arkansas
    CHI Saint Vincent Cancer Center Hot Springs  
  • Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  
    Principal Investigator: Richard L. Deming        

California

Mission Hope Medical Oncology - Arroyo Grande   

Arroyo Grande, California  

Contact: Site Public Contact    916-851-2283    research@dignityhealth.org  

Principal Investigator: Richard L. Deming         

 

Sutter Auburn Faith Hospital

Auburn, California  

Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org  

Principal Investigator: Ari D. Baron        

 

Sutter Cancer Centers Radiation Oncology Services-Auburn

Auburn, California  

Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org  

Principal Investigator: Ari D. Baron        

 

Alta Bates Summit Medical Center-Herrick Campus

Berkeley, California  

Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org  

Principal Investigator: Ari D. Baron   

    

Sutter Cancer Centers Radiation Oncology Services-Cameron Park

Cameron Park, California  

Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org  

Principal Investigator: Ari D. Baron        

 

Eden Hospital Medical Center          

Castro Valley, California  

Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org   

Principal Investigator: Ari D. Baron   

    

Sutter Davis Hospital 

Davis, California  

Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org  

Principal Investigator: Ari D. Baron        

 

City of Hope Comprehensive Cancer Center

Duarte, California  

Contact: Site Public Contact    800-826-4673    becomingapatient@coh.org  

Principal Investigator: Vincent Chung        

 

Palo Alto Medical Foundation-Fremont       

Fremont, California  

Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org  

Principal Investigator: Ari D. Baron        

 

Memorial Medical Center     

Modesto, California  

Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org  

Principal Investigator: Ari D. Baron        

 

Palo Alto Medical Foundation-Camino Division       

Mountain View, California  

Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org  

Principal Investigator: Ari D. Baron 

      

Palo Alto Medical Foundation-Gynecologic Oncology          

Mountain View, California  

Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org  

Principal Investigator: Ari D. Baron  

     

Palo Alto Medical Foundation Health Care   

Palo Alto, California  

Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org  

Principal Investigator: Ari D. Baron

       

Sutter Cancer Centers Radiation Oncology Services-Roseville         

Roseville, California  

Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org  

Principal Investigator: Ari D. Baron        

 

Sutter Roseville Medical Center        

Roseville, California  

Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org  

Principal Investigator: Ari D. Baron        

 

Sutter Medical Center Sacramento   

Sacramento, California  

Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org  

Principal Investigator: Ari D. Baron        

 

California Pacific Medical Center-Pacific Campus    

San Francisco, California  

Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org  

Principal Investigator: Ari D. Baron        

 

Pacific Central Coast Health Center-San Luis Obispo

San Luis Obispo, California  

Contact: Site Public Contact       Diane.DeVos-Schmidt@DignityHealth.org  

Principal Investigator: Richard L. Deming        

 

Mills Health Center   

San Mateo, California  

Contact: Site Public Contact       protocols@swog.org  

Principal Investigator: Ari D. Baron        

 

Palo Alto Medical Foundation-Santa Cruz    

Santa Cruz, California  

Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org  

Principal Investigator: Ari D. Baron        

 

Mission Hope Medical Oncology - Santa Maria        

Santa Maria, California  

Contact: Site Public Contact    916-851-2283    research@dignityhealth.org  

Principal Investigator: Richard L. Deming      

 

Sutter Pacific Medical Foundation    

Santa Rosa, California  

Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org  

Principal Investigator: Ari D. Baron        

 

Palo Alto Medical Foundation-Sunnyvale     

Sunnyvale, California  

Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org  

Principal Investigator: Ari D. Baron       

 

Sutter Cancer Centers Radiation Oncology Services-Vacaville         

Vacaville, California  

Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org  

Principal Investigator: Ari D. Baron     

   

Sutter Solano Medical Center/Cancer Center          

Vallejo, California  

Contact: Site Public Contact    415-209-2686    bernicl@sutterhealth.org  

Principal Investigator: Ari D. Baron        

 

Colorado

Penrose-Saint Francis Healthcare     

Colorado Springs, Colorado  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

Rocky Mountain Cancer Centers-Penrose    

Colorado Springs, Colorado  

Contact: Site Public Contact    303-777-2663    info@westernstatesncorp.org  

Principal Investigator: Richard L. Deming

        

Porter Adventist Hospital     

Denver, Colorado  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

Mercy Medical Center           

Durango, Colorado  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming  

     

Southwest Oncology PC        

Durango, Colorado  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

Saint Anthony Hospital         

Lakewood, Colorado  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

Littleton Adventist Hospital  

Littleton, Colorado  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming

        

Longmont United Hospital    

Longmont, Colorado  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

Rocky Mountain Cancer Centers-Longmont 

Longmont, Colorado  

Contact: Site Public Contact    303-777-2663    info@westernstatesncorp.org  

Principal Investigator: Richard L. Deming        

 

Parker Adventist Hospital     

Parker, Colorado  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming

        

Saint Mary Corwin Medical Center   

Pueblo, Colorado  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming     

  

Connecticut

Danbury Hospital      

Danbury, Connecticut  

Contact: Site Public Contact    203-739-8074     

Principal Investigator: Wenli Gao        

 

Norwalk Hospital       

Norwalk, Connecticut  

Contact: Site Public Contact    203-852-2996    jennifer.long@norwalkhealth.org  

Principal Investigator: Richard C. Frank        

 

Florida

Mount Sinai Comprehensive Cancer Center at Aventura     

Aventura, Florida  

Contact: Site Public Contact    305-674-2625    yenrique@msmc.com  

Principal Investigator: Mike Cusnir 

      

Holy Cross Hospital   

Fort Lauderdale, Florida  

Contact: Site Public Contact    954-267-7750     

Principal Investigator: Philip J. Stella    

   

Mount Sinai Medical Center 

Miami Beach, Florida  

Contact: Site Public Contact    305-674-2625    yenrique@msmc.com  

Principal Investigator: Mike Cusnir    

   

Idaho

Saint Alphonsus Cancer Care Center-Boise  

Boise, Idaho  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: John M. Schallenkamp        

 

Saint Alphonsus Cancer Care Center-Caldwell         

Caldwell, Idaho  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: John M. Schallenkamp   

    

Kootenai Medical Center      

Coeur d'Alene, Idaho  

Contact: Site Public Contact    406-969-6060    mccinfo@mtcancer.org  

Principal Investigator: John M. Schallenkamp        

 

Walter Knox Memorial Hospital       

Emmett, Idaho  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: John M. Schallenkamp        

 

Idaho Urologic Institute-Meridian    

Meridian, Idaho  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: John M. Schallenkamp       

 

Saint Alphonsus Medical Center-Nampa      

Nampa, Idaho  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: John M. Schallenkamp       

 

Kootenai Cancer Center        

Post Falls, Idaho  

Contact: Site Public Contact    406-969-6060    mccinfo@mtcancer.org  

Principal Investigator: John M. Schallenkamp       

 

Kootenai Cancer Clinic          

Sandpoint, Idaho  

Contact: Site Public Contact    406-969-6060    mccinfo@mtcancer.org  

Principal Investigator: John M. Schallenkamp        

 

Illinois

Rush - Copley Medical Center

Aurora, Illinois  

Contact: Site Public Contact    630-978-6212    Cancer.Research@rushcopley.com  

Principal Investigator: Suparna Mantha

       

Illinois CancerCare-Bloomington      

Bloomington, Illinois  

Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com  

Principal Investigator: Bryan A. Faller        

 

Illinois CancerCare-Canton   

Canton, Illinois  

Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com  

Principal Investigator: Bryan A. Faller       

 

Memorial Hospital of Carbondale    

Carbondale, Illinois  

Contact: Site Public Contact    618-457-5200    clinical.research@sih.net  

Principal Investigator: Bryan A. Faller     

  

SIH Cancer Institute  

Carterville, Illinois  

Contact: Site Public Contact    618-985-3333    clinical.research@sih.net  

Principal Investigator: Bryan A. Faller        

 

Illinois CancerCare-Carthage 

Carthage, Illinois  

Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com  

Principal Investigator: Bryan A. Faller        

 

Centralia Oncology Clinic      

Centralia, Illinois  

Contact: Site Public Contact    217-876-4740    rhamrick@dmhhs.org  

Principal Investigator: Bryan A. Faller        

 

Northwestern University      

Chicago, Illinois  

Contact: Site Public Contact    312-695-1301    cancer@northwestern.edu  

Principal Investigator: Aparna Kalyan        

 

Carle on Vermilion    

Danville, Illinois  

Contact: Site Public Contact    800-446-5532    Research@carle.com  

Principal Investigator: Suparna Mantha     

  

Cancer Care Specialists of Illinois - Decatur  

Decatur, Illinois  

Contact: Site Public Contact    217-876-4740    rhamrick@dmhhs.org  

Principal Investigator: Bryan A. Faller        

 

Decatur Memorial Hospital  

Decatur, Illinois  

Contact: Site Public Contact    217-876-4740    rhamrick@dmhhs.org  

Principal Investigator: Bryan A. Faller      

 

Illinois CancerCare-Dixon      

Dixon, Illinois  

Contact: Site Public Contact    815-285-7800     

Principal Investigator: Bryan A. Faller    

   

Carle Physician Group-Effingham     

Effingham, Illinois  

Contact: Site Public Contact    800-446-5532    Research@carle.com  

Principal Investigator: Suparna Mantha 

      

Crossroads Cancer Center     

Effingham, Illinois  

Contact: Site Public Contact    217-876-4740    rhamrick@dmhhs.org  

Principal Investigator: Bryan A. Faller        

 

Illinois CancerCare-Galesburg

Galesburg, Illinois  

Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com  

Principal Investigator: Bryan A. Faller     

  

Western Illinois Cancer Treatment Center   

Galesburg, Illinois  

Contact: Site Public Contact    309-344-2831     

Principal Investigator: Bryan A. Faller        

 

Illinois CancerCare-Kewanee Clinic   

Kewanee, Illinois  

Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com  

Principal Investigator: Bryan A. Faller    

   

Northwestern Medicine Lake Forest Hospital          

Lake Forest, Illinois  

Contact: Site Public Contact       cancertrials@northwestern.edu  

Principal Investigator: Aparna Kalyan        

 

Illinois CancerCare-Macomb 

Macomb, Illinois  

Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com  

Principal Investigator: Bryan A. Faller        

 

Carle Physician Group-Mattoon/Charleston

Mattoon, Illinois  

Contact: Site Public Contact    800-446-5532    Research@carle.com  

Principal Investigator: Suparna Mantha        

 

Good Samaritan Regional Health Center      

Mount Vernon, Illinois  

Contact: Site Public Contact    618-242-4600     

Principal Investigator: Jay W. Carlson        

 

Cancer Care Center of O'Fallon         

O'Fallon, Illinois  

Contact: Site Public Contact    217-876-4762    morganthaler.jodi@mhsil.com  

Principal Investigator: Bryan A. Faller        

 

Illinois CancerCare-Ottawa Clinic      

Ottawa, Illinois  

Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com  

Principal Investigator: Bryan A. Faller        

 

Illinois CancerCare-Pekin      

Pekin, Illinois  

Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com  

Principal Investigator: Bryan A. Faller       

 

Illinois CancerCare-Peoria     

Peoria, Illinois  

Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com  

Principal Investigator: Bryan A. Faller  

     

Methodist Medical Center of Illinois

Peoria, Illinois  

Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com  

Principal Investigator: Bryan A. Faller     

  

Illinois CancerCare-Peru        

Peru, Illinois  

Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com  

Principal Investigator: Bryan A. Faller    

   

Valley Radiation Oncology    

Peru, Illinois  

Contact: Site Public Contact    815-664-4141     

Principal Investigator: Bryan A. Faller        

 

Illinois CancerCare-Princeton

Princeton, Illinois  

Contact: Site Public Contact    309-243-3605    andersonj@illinoiscancercare.com  

Principal Investigator: Bryan A. Faller     

  

Southern Illinois University School of Medicine       

Springfield, Illinois  

Contact: Site Public Contact    217-545-7929     

Principal Investigator: Bryan A. Faller        

 

Springfield Clinic        

Springfield, Illinois  

Contact: Site Public Contact    800-444-7541     

Principal Investigator: Bryan A. Faller    

   

Memorial Medical Center     

Springfield, Illinois  

Contact: Site Public Contact    217-788-3528     

Principal Investigator: Bryan A. Faller     

  

Carle Cancer Center  

Urbana, Illinois  

Contact: Site Public Contact    800-446-5532    Research@carle.com  

Principal Investigator: Suparna Mantha   

    

The Carle Foundation Hospital         

Urbana, Illinois  

Contact: Site Public Contact    800-446-5532    Research@carle.com  

Principal Investigator: Suparna Mantha        

 

Rush-Copley Healthcare Center        

Yorkville, Illinois  

Contact: Site Public Contact    630-978-6212    Cancer.Research@rushcopley.com  

Principal Investigator: Suparna Mantha        

 

Indiana

Indiana University/Melvin and Bren Simon Cancer Center  

Indianapolis, Indiana  

Contact: Site Public Contact    317-278-5632    iutrials@iu.edu  

Principal Investigator: Anita Turk        

 

Iowa

Mary Greeley Medical Center

Ames, Iowa  

Contact: Site Public Contact    515-956-4132     

Principal Investigator: Debra M. Prow   

    

McFarland Clinic PC - Ames   

Ames, Iowa  

Contact: Site Public Contact    515-239-4734    ksoder@mcfarlandclinic.com  

Principal Investigator: Debra M. Prow    

   

McFarland Clinic PC-Boone   

Boone, Iowa  

Contact: Site Public Contact    515-956-4132     

Principal Investigator: Debra M. Prow        

 

Medical Oncology and Hematology Associates-West Des Moines  

Clive, Iowa  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

Mercy Cancer Center-West Lakes     

Clive, Iowa  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming      

 

Alegent Health Mercy Hospital         

Council Bluffs, Iowa  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

Greater Regional Medical Center      

Creston, Iowa  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

Iowa Methodist Medical Center       

Des Moines, Iowa  

Contact: Site Public Contact    515-241-6727     

Principal Investigator: Robert J. Behrens        

 

Medical Oncology and Hematology Associates-Des Moines

Des Moines, Iowa  

Contact: Site Public Contact    515-282-2921     

Principal Investigator: Robert J. Behrens        

 

Broadlawns Medical Center  

Des Moines, Iowa  

Contact: Site Public Contact    515-282-2200     

Principal Investigator: Robert J. Behrens        

 

Medical Oncology and Hematology Associates-Laurel        

Des Moines, Iowa  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

Mercy Medical Center - Des Moines 

Des Moines, Iowa  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

Iowa Lutheran Hospital         

Des Moines, Iowa  

Contact: Site Public Contact    515-241-8704     

Principal Investigator: Robert J. Behrens     

  

McFarland Clinic PC-Trinity Cancer Center   

Fort Dodge, Iowa  

Contact: Site Public Contact    515-956-4132     

Principal Investigator: Debra M. Prow      

 

Trinity Regional Medical Center        

Fort Dodge, Iowa  

Contact: Site Public Contact    515-574-8302     

Principal Investigator: Robert J. Behrens     

  

McFarland Clinic PC-Jefferson           

Jefferson, Iowa  

Contact: Site Public Contact    515-956-4132     

Principal Investigator: Debra M. Prow        

 

McFarland Clinic PC-Marshalltown   

Marshalltown, Iowa  

Contact: Site Public Contact    515-956-4132     

Principal Investigator: Debra M. Prow        

 

Methodist West Hospital      

West Des Moines, Iowa  

Contact: Site Public Contact    515-343-1000     

Principal Investigator: Robert J. Behrens        

 

Mercy Medical Center-West Lakes   

West Des Moines, Iowa  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

Kentucky

Flaget Memorial Hospital     

Bardstown, Kentucky  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

Commonwealth Cancer Center-Corbin        

Corbin, Kentucky  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming  

     

Saint Joseph Radiation Oncology Resource Center  

Lexington, Kentucky  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming 

      

Saint Joseph Hospital East    

Lexington, Kentucky  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming  

     

Saint Joseph London 

London, Kentucky  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming      

 

Jewish Hospital         

Louisville, Kentucky  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

Saints Mary and Elizabeth Hospital  

Louisville, Kentucky  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

Jewish Hospital Medical Center Northeast  

Louisville, Kentucky  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming     

  

Jewish Hospital Medical Center South         

Shepherdsville, Kentucky  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming       

 

Michigan

Hickman Cancer Center         

Adrian, Michigan  

Contact: Site Public Contact    517-265-0116     

Principal Investigator: Rex B. Mowat  

     

Saint Joseph Mercy Hospital 

Ann Arbor, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella      

 

Bronson Battle Creek

Battle Creek, Michigan  

Contact: Site Public Contact    616-391-1230    crcwm-regulatory@crcwm.org  

Principal Investigator: Kathleen J. Yost        

 

IHA Hematology Oncology Consultants-Brighton    

Brighton, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella        

 

Saint Joseph Mercy Brighton

Brighton, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella       

 

IHA Hematology Oncology Consultants-Canton       

Canton, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella    

   

Saint Joseph Mercy Canton   

Canton, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella   

    

Caro Cancer Center   

Caro, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella       

 

IHA Hematology Oncology Consultants-Chelsea      

Chelsea, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella        

 

Saint Joseph Mercy Chelsea  

Chelsea, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella       

 

Hematology Oncology Consultants-Clarkston          

Clarkston, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella       

 

Newland Medical Associates-Clarkston        

Clarkston, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella        

 

Ascension Saint John Hospital          

Detroit, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella        

 

Great Lakes Cancer Management Specialists-Doctors Park 

East China Township, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella        

 

Genesee Cancer and Blood Disease Treatment Center        

Flint, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella        

 

Genesee Hematology Oncology PC   

Flint, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella        

 

Genesys Hurley Cancer Institute       

Flint, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella        

 

Hurley Medical Center          

Flint, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella        

 

Helen DeVos Children's Hospital at Spectrum Health          

Grand Rapids, Michigan  

Contact: Site Public Contact    616-391-1230    crcwm-regulatory@crcwm.org  

Principal Investigator: Kathleen J. Yost    

   

Mercy Health Saint Mary's    

Grand Rapids, Michigan  

Contact: Site Public Contact    616-391-1230    crcwm-regulatory@crcwm.org  

Principal Investigator: Kathleen J. Yost     

  

Spectrum Health at Butterworth Campus    

Grand Rapids, Michigan  

Contact: Site Public Contact    616-391-1230    crcwm-regulatory@crcwm.org  

Principal Investigator: Kathleen J. Yost        

 

Academic Hematology Oncology Specialists

Grosse Pointe Woods, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella        

 

Great Lakes Cancer Management Specialists-Van Elslander Cancer Center

Grosse Pointe Woods, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella        

 

Michigan Breast Specialists-Grosse Pointe Woods  

Grosse Pointe Woods, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella        

 

Bronson Methodist Hospital 

Kalamazoo, Michigan  

Contact: Site Public Contact    616-391-1230    crcwm-regulatory@crcwm.org  

Principal Investigator: Kathleen J. Yost 

      

West Michigan Cancer Center          

Kalamazoo, Michigan  

Contact: Site Public Contact    616-391-1230    crcwm-regulatory@crcwm.org  

Principal Investigator: Kathleen J. Yost

       

Borgess Medical Center        

Kalamazoo, Michigan  

Contact: Site Public Contact    616-391-1230    crcwm-regulatory@crcwm.org  

Principal Investigator: Kathleen J. Yost        

 

Sparrow Hospital      

Lansing, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella        

 

Hope Cancer Clinic    

Livonia, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella        

 

Saint Mary Mercy Hospital   

Livonia, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella        

 

Great Lakes Cancer Management Specialists-Macomb Medical Campus   

Macomb, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella        

 

Michigan Breast Specialists-Macomb Township      

Macomb, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella        

 

Saint Mary's Oncology/Hematology Associates of Marlette

Marlette, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella   

    

Toledo Clinic Cancer Centers-Monroe          

Monroe, Michigan  

Contact: Site Public Contact    800-444-3561     

Principal Investigator: Rex B. Mowat        

 

Mercy Health Mercy Campus

Muskegon, Michigan  

Contact: Site Public Contact    616-391-1230    crcwm-regulatory@crcwm.org  

Principal Investigator: Kathleen J. Yost        

 

Lakeland Hospital Niles         

Niles, Michigan  

Contact: Site Public Contact    616-391-1230     

Principal Investigator: Kathleen J. Yost        

 

Cancer and Hematology Centers of Western Michigan - Norton Shores     

Norton Shores, Michigan  

Contact: Site Public Contact    616-391-1230    connie.szczepanek@crcwm.org  

Principal Investigator: Kathleen J. Yost        

 

Ascension Providence Hospitals - Novi         

Novi, Michigan  

Contact: Site Public Contact    248-849-5332    karen.fife@ascension.org  

Principal Investigator: Susan E. Lyons        

 

21st Century Oncology-Pontiac        

Pontiac, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella        

 

Hope Cancer Center  

Pontiac, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella      

 

Newland Medical Associates-Pontiac

Pontiac, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella     

  

Saint Joseph Mercy Oakland 

Pontiac, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella    

   

Spectrum Health Reed City Hospital 

Reed City, Michigan  

Contact: Site Public Contact    616-391-1230    crcwm-regulatory@crcwm.org  

Principal Investigator: Kathleen J. Yost        

 

Ascension Saint Mary's Hospital       

Saginaw, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella     

  

Oncology Hematology Associates of Saginaw Valley PC       

Saginaw, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella        

 

Lakeland Medical Center Saint Joseph          

Saint Joseph, Michigan  

Contact: Site Public Contact    616-391-1230    crcwm-regulatory@crcwm.org  

Principal Investigator: Kathleen J. Yost   

    

Marie Yeager Cancer Center 

Saint Joseph, Michigan  

Contact: Site Public Contact    616-391-1230    crcwm-regulatory@crcwm.org  

Principal Investigator: Kathleen J. Yost        

 

Ascension Providence Hospitals - Southfield

Southfield, Michigan  

Contact: Site Public Contact    248-849-5332    karen.fife@ascension.org  

Principal Investigator: Susan E. Lyons        

 

Bhadresh Nayak MD PC-Sterling Heights      

Sterling Heights, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella        

 

Ascension Saint Joseph Hospital       

Tawas City, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella         

 

Munson Medical Center        

Traverse City, Michigan  

Contact: Site Public Contact    616-391-1230    crcwm-regulatory@crcwm.org  

Principal Investigator: Kathleen J. Yost        

 

Advanced Breast Care Center PLLC   

Warren, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella        

 

Great Lakes Cancer Management Specialists-Macomb Professional Building        

Warren, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella        

 

Macomb Hematology Oncology PC   

Warren, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella        

 

Michigan Breast Specialists-Warren 

Warren, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella        

 

Saint John Macomb-Oakland Hospital          

Warren, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella        

 

Saint Mary's Oncology/Hematology Associates of West Branch     

West Branch, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella 

      

Metro Health Hospital          

Wyoming, Michigan  

Contact: Site Public Contact    616-391-1230    crcwm-regulatory@crcwm.org  

Principal Investigator: Kathleen J. Yost    

   

Huron Gastroenterology PC  

Ypsilanti, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella        

 

IHA Hematology Oncology Consultants-Ann Arbor  

Ypsilanti, Michigan  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella       

 

Minnesota

Fairview Ridges Hospital       

Burnsville, Minnesota  

Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com  

Principal Investigator: David M. King  

     

Minnesota Oncology - Burnsville      

Burnsville, Minnesota  

Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com  

Principal Investigator: David M. King        

 

Cambridge Medical Center   

Cambridge, Minnesota  

Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com  

Principal Investigator: David M. King        

 

Mercy Hospital          

Coon Rapids, Minnesota  

Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com  

Principal Investigator: David M. King        

 

Fairview Southdale Hospital 

Edina, Minnesota   55435

Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com  

Principal Investigator: David M. King        

 

Unity Hospital

Fridley, Minnesota  

Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com  

Principal Investigator: David M. King        

 

Fairview Clinics and Surgery Center Maple Grove    

Maple Grove, Minnesota  

Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com  

Principal Investigator: David M. King        

 

Minnesota Oncology Hematology PA-Maplewood  

Maplewood, Minnesota  

Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com  

Principal Investigator: David M. King        

 

Saint John's Hospital - Healtheast    

Maplewood, Minnesota  

Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com  

Principal Investigator: David M. King        

 

Abbott-Northwestern Hospital         

Minneapolis, Minnesota  

Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com  

Principal Investigator: David M. King      

 

Hennepin County Medical Center     

Minneapolis, Minnesota  

Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com  

Principal Investigator: David M. King     

  

Health Partners Inc    

Minneapolis, Minnesota  

Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com  

Principal Investigator: David M. King        

 

Monticello Cancer Center     

Monticello, Minnesota  

Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com  

Principal Investigator: David M. King    

   

New Ulm Medical Center      

New Ulm, Minnesota  

Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com  

Principal Investigator: David M. King        

 

Fairview Northland Medical Center  

Princeton, Minnesota  

Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com  

Principal Investigator: David M. King        

 

North Memorial Medical Health Center       

Robbinsdale, Minnesota  

Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com  

Principal Investigator: David M. King        

 

Park Nicollet Clinic - Saint Louis Park

Saint Louis Park, Minnesota  

Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com  

Principal Investigator: David M. King        

 

Regions Hospital       

Saint Paul, Minnesota  

Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com  

Principal Investigator: David M. King        

 

United Hospital         

Saint Paul, Minnesota  

Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com  

Principal Investigator: David M. King        

 

Saint Francis Regional Medical Center          

Shakopee, Minnesota  

Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com  

Principal Investigator: David M. King  

     

Lakeview Hospital     

Stillwater, Minnesota  

Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com  

Principal Investigator: David M. King        

 

Ridgeview Medical Center    

Waconia, Minnesota  

Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com  

Principal Investigator: David M. King        

 

Rice Memorial Hospital         

Willmar, Minnesota  

Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com  

Principal Investigator: David M. King        

 

Minnesota Oncology Hematology PA-Woodbury    

Woodbury, Minnesota  

Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com  

Principal Investigator: David M. King        

 

Fairview Lakes Medical Center          

Wyoming, Minnesota  

Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com  

Principal Investigator: David M. King       

 

Missouri

Saint Louis Cancer and Breast Institute-Ballwin       

Ballwin, Missouri  

Contact: Site Public Contact    314-251-7058     

Principal Investigator: Jay W. Carlson       

 

Saint Francis Medical Center 

Cape Girardeau, Missouri  

Contact: Site Public Contact    573-334-2230    sfmc@sfmc.net  

Principal Investigator: Bryan A. Faller    

   

Southeast Cancer Center      

Cape Girardeau, Missouri  

Contact: Site Public Contact    573-651-5550     

Principal Investigator: Bryan A. Faller        

 

Parkland Health Center - Farmington

Farmington, Missouri  

Contact: Site Public Contact    314-996-5569     

Principal Investigator: Bryan A. Faller   

    

Capital Region Southwest Campus   

Jefferson City, Missouri  

Contact: Site Public Contact    573-632-4814    swooden@mail.crmc.org  

Principal Investigator: Bryan A. Faller     

  

Freeman Health System        

Joplin, Missouri  

Contact: Site Public Contact    417-347-4030    LJCrockett@freemanhealth.com  

Principal Investigator: Jay W. Carlson 

      

Mercy Hospital Joplin

Joplin, Missouri  

Contact: Site Public Contact    417-556-3074    esmeralda.carrillo@mercy.net  

Principal Investigator: Jay W. Carlson       

 

Delbert Day Cancer Institute at PCRMC        

Rolla, Missouri  

Contact: Site Public Contact    573-458-8776    kaysmith@phelpshealth.org  

Principal Investigator: Jay W. Carlson        

 

Mercy Clinic-Rolla-Cancer and Hematology 

Rolla, Missouri  

Contact: Site Public Contact    573-458-6379     

Principal Investigator: Jay W. Carlson        

 

Heartland Regional Medical Center  

Saint Joseph, Missouri  

Contact: Site Public Contact    816-271-7937    linda.schumacher@mymlc.com  

Principal Investigator: Jay W. Carlson        

 

Saint Louis Cancer and Breast Institute-South City  

Saint Louis, Missouri  

Contact: Site Public Contact    314-353-1870     

Principal Investigator: Jay W. Carlson   

    

Mercy Hospital South

Saint Louis, Missouri  

Contact: Site Public Contact       janet.lesko@mercy.net  

Principal Investigator: Jay W. Carlson        

 

Missouri Baptist Medical Center       

Saint Louis, Missouri  

Contact: Site Public Contact    314-996-5569     

Principal Investigator: Bryan A. Faller        

 

Mercy Hospital Saint Louis    

Saint Louis, Missouri  

Contact: Site Public Contact    314-251-7066     

Principal Investigator: Jay W. Carlson        

 

Sainte Genevieve County Memorial Hospital

Sainte Genevieve, Missouri  

Contact: Site Public Contact    314-996-5569     

Principal Investigator: Bryan A. Faller    

   

Mercy Hospital Springfield    

Springfield, Missouri  

Contact: Site Public Contact    417-269-4520     

Principal Investigator: Jay W. Carlson        

 

CoxHealth South Hospital     

Springfield, Missouri  

Contact: Site Public Contact    417-269-4520     

Principal Investigator: Jay W. Carlson        

 

Missouri Baptist Sullivan Hospital    

Sullivan, Missouri  

Contact: Site Public Contact    314-996-5569     

Principal Investigator: Bryan A. Faller        

 

Missouri Baptist Outpatient Center-Sunset Hills      

Sunset Hills, Missouri  

Contact: Site Public Contact    314-996-5569     

Principal Investigator: Bryan A. Faller    

   

Mercy Hospital Washington 

Washington, Missouri  

Contact: Site Public Contact    636-390-1600     

Principal Investigator: Jay W. Carlson        

 

Montana

Community Hospital of Anaconda    

Anaconda, Montana  

Contact: Site Public Contact    406-969-6060    mccinfo@mtcancer.org  

Principal Investigator: John M. Schallenkamp        

 

Billings Clinic Cancer Center  

Billings, Montana  

Contact: Site Public Contact    800-996-2663    research@billingsclinic.org  

Principal Investigator: John M. Schallenkamp        

 

Bozeman Deaconess Hospital

Bozeman, Montana  

Contact: Site Public Contact    406-969-6060    mccinfo@mtcancer.org  

Principal Investigator: John M. Schallenkamp        

 

Benefis Healthcare- Sletten Cancer Institute

Great Falls, Montana  

Contact: Site Public Contact    406-969-6060    mccinfo@mtcancer.org  

Principal Investigator: John M. Schallenkamp        

 

Great Falls Clinic        

Great Falls, Montana  

Contact: Site Public Contact    406-969-6060    mccinfo@mtcancer.org  

Principal Investigator: John M. Schallenkamp        

 

Kalispell Regional Medical Center     

Kalispell, Montana  

Contact: Site Public Contact    406-969-6060    mccinfo@mtcancer.org  

Principal Investigator: John M. Schallenkamp   

    

Community Medical Hospital

Missoula, Montana  

Contact: Site Public Contact    406-969-6060    mccinfo@mtcancer.org  

Principal Investigator: John M. Schallenkamp        

 

Nebraska

CHI Health Saint Francis        

Grand Island, Nebraska  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

CHI Health Good Samaritan  

Kearney, Nebraska  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming     

  

Saint Elizabeth Regional Medical Center      

Lincoln, Nebraska  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming    

   

Nebraska Methodist Hospital

Omaha, Nebraska  

Contact: Site Public Contact    402-354-5144     

Principal Investigator: Timothy Huyck        

 

Alegent Health Immanuel Medical Center   

Omaha, Nebraska  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

Alegent Health Bergan Mercy Medical Center         

Omaha, Nebraska  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

Alegent Health Lakeside Hospital     

Omaha, Nebraska  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

Creighton University Medical Center

Omaha, Nebraska  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

Midlands Community Hospital         

Papillion, Nebraska  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

North Carolina

Southeastern Medical Oncology Center-Clinton      

Clinton, North Carolina  

Contact: Site Public Contact    919-587-9084    jfields@cancersmoc.com  

Principal Investigator: Samer S. Kasbari        

 

Southeastern Medical Oncology Center-Goldsboro 

Goldsboro, North Carolina  

Contact: Site Public Contact    919-587-9084    jfields@cancersmoc.com  

Principal Investigator: Samer S. Kasbari        

 

Southeastern Medical Oncology Center-Jacksonville

Jacksonville, North Carolina  

Contact: Site Public Contact    910-587-9084    jfields@cancersmoc.com  

Principal Investigator: Samer S. Kasbari        

 

Vidant Oncology-Kenansville

Kenansville, North Carolina  

Contact: Site Public Contact    252-559-2201    Carla.Zimmerman@vidanthealth.com  

Principal Investigator: Misbah U. Qadir        

 

Vidant Oncology-Kinston      

Kinston, North Carolina  

Contact: Site Public Contact    252-559-2201    Carla.Zimmerman@vidanthealth.com  

Principal Investigator: Misbah U. Qadir        

 

Vidant Oncology-Richlands   

Richlands, North Carolina  

Contact: Site Public Contact    252-559-2201    Carla.Zimmerman@vidanthealth.com  

Principal Investigator: Misbah U. Qadir        

 

Ohio

Good Samaritan Hospital - Cincinnati

Cincinnati, Ohio  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

Bethesda North Hospital       

Cincinnati, Ohio  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

TriHealth Cancer Institute-Westside

Cincinnati, Ohio  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

TriHealth Cancer Institute-Anderson

Cincinnati, Ohio  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

Mercy Health - Saint Anne Hospital  

Toledo, Ohio  

Contact: Site Public Contact    614-488-2118    sheree@columbusccop.org  

Principal Investigator: Rex B. Mowat        

 

Toledo Clinic Cancer Centers-Toledo

Toledo, Ohio  

Contact: Site Public Contact    800-444-3561     

Principal Investigator: Rex B. Mowat        

 

Oklahoma

Cancer Centers of Southwest Oklahoma Research  

Lawton, Oklahoma  

Contact: Site Public Contact    877-231-4440     

Principal Investigator: Sagila George        

 

University of Oklahoma Health Sciences Center      

Oklahoma City, Oklahoma  

Contact: Site Public Contact    405-271-8777    ou-clinical-trials@ouhsc.edu  

Principal Investigator: Sagila George        

 

Integris Southwest Medical Center   

Oklahoma City, Oklahoma  

Contact: Site Public Contact    888-823-5923    ctsucontact@westat.com  

Principal Investigator: Sagila George    

   

Mercy Hospital Oklahoma City         

Oklahoma City, Oklahoma  

Contact: Site Public Contact    405-752-3402     

Principal Investigator: Jay W. Carlson        

 

Oregon

Saint Alphonsus Medical Center-Baker City 

Baker City, Oregon  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: John M. Schallenkamp        

 

Saint Alphonsus Medical Center-Ontario     

Ontario, Oregon  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: John M. Schallenkamp

       

Pennsylvania

Lehigh Valley Hospital-Cedar Crest   

Allentown, Pennsylvania  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella      

 

Lehigh Valley Hospital - Muhlenberg

Bethlehem, Pennsylvania  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella   

    

Pocono Medical Center         

East Stroudsburg, Pennsylvania  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella        

 

Saint Vincent Hospital

Erie, Pennsylvania  

Contact: Site Public Contact    814-452-5000     

Principal Investigator: Dulabh K. Monga      

 

Lehigh Valley Hospital-Hazleton       

Hazleton, Pennsylvania  

Contact: Site Public Contact    734-712-3671    stephanie.couch@stjoeshealth.org  

Principal Investigator: Philip J. Stella      

 

Jefferson Hospital     

Jefferson Hills, Pennsylvania  

Contact: Site Public Contact    412-359-3043    ddefazio@wpahs.org   

Principal Investigator: Dulabh K. Monga        

 

Forbes Hospital         

Monroeville, Pennsylvania  

Contact: Site Public Contact    412-858-7746     

Principal Investigator: Dulabh K. Monga        

 

Allegheny General Hospital  

Pittsburgh, Pennsylvania   

Contact: Site Public Contact    877-284-2000     

Principal Investigator: Dulabh K. Monga        

 

West Penn Hospital   

Pittsburgh, Pennsylvania  

Contact: Site Public Contact    412-578-5000     

Principal Investigator: Dulabh K. Monga        

 

Wexford Health and Wellness Pavilion        

Wexford, Pennsylvania  

Contact: Site Public Contact    412-359-3043    ddefazio@wpahs.org  

Principal Investigator: Dulabh K. Monga        

 

Texas

Hendrick Medical Center       

Abilene, Texas  

Contact: Site Public Contact    325-670-6340     

Principal Investigator: Mustapha A. Khalife        

 

Saint Joseph Regional Cancer Center

Bryan, Texas  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

Washington

Harrison HealthPartners Hematology and Oncology-Bremerton    

Bremerton, Washington  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming         

 

Harrison Medical Center       

Bremerton, Washington  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

Highline Medical Center-Main Campus        

Burien, Washington  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

Saint Elizabeth Hospital        

Enumclaw, Washington  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming 

      

Saint Francis Hospital

Federal Way, Washington  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

Saint Clare Hospital   

Lakewood, Washington  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

Harrison HealthPartners Hematology and Oncology-Poulsbo         

Poulsbo, Washington  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

Franciscan Research Center-Northwest Medical Plaza        

Tacoma, Washington  

Contact: Site Public Contact    308-398-6518    clinicaltrials@sfmc-gi.org  

Principal Investigator: Richard L. Deming        

 

Northwest Medical Specialties PLLC 

Tacoma, Washington  

Contact: Site Public Contact    253-306-0532    research@southsoundcare.org  

Principal Investigator: Richard L. Deming        

 

Wisconsin

ProHealth D N Greenwald Center     

Mukwonago, Wisconsin  

Contact: Site Public Contact       research.institute@phci.org  

Principal Investigator: Timothy R. Wassenaar        

 

Cancer Center of Western Wisconsin

New Richmond, Wisconsin  

Contact: Site Public Contact    952-993-1517    mmcorc@healthpartners.com  

Principal Investigator: David M. King        

 

ProHealth Oconomowoc Memorial Hospital

Oconomowoc, Wisconsin  

Contact: Site Public Contact    262-928-7878     

Principal Investigator: Timothy R. Wassenaar   

    

ProHealth Waukesha Memorial Hospital     

Waukesha, Wisconsin  

Contact: Site Public Contact    262-928-7632     

Principal Investigator: Timothy R. Wassenaar        

 

UW Cancer Center at ProHealth Care

Waukesha, Wisconsin  

Contact: Site Public Contact    262-928-5539    Chanda.miller@phci.org  

Principal Investigator: Timothy R. Wassenaar        

 

Wyoming

Billings Clinic-Cody    

Cody, Wyoming  

Contact: Site Public Contact    800-996-2663    research@billingsclinic.org  

Principal Investigator: John M. Schallenkamp    

   

Welch Cancer Center

Sheridan, Wyoming  

Contact: Site Public Contact    406-969-6060    mccinfo@mtcancer.org  

Principal Investigator: John M. Schallenkamp        

This Study is Open To:

Men and women age 18 years or older can participate if they meet the following criteria:

  • Have pancreatic cancer.
  • Have a hereditary or mutation.
  • Have received first line platinum-based chemotherapy (i.e. fluorouracil, irinotecan, leucovorin and oxaliplatin [FOLFIRINOX], leucovorin calcium, 5-fluorouracil, and oxaliplatin [FOLFOX], or gemcitabine + cisplatin) for at least 16 weeks but no more than 24 weeks.
  • Have had a or showing stable or responding disease on first line platinum-based chemotherapy within 30 days prior to registration.
This Study is Not Open To:

People are not eligible to participate if they:

  • have with a known hypersensitivity to olaparib.
  • have already received a type of  known as an immune checkpoint inhibitor.
  • have had prior therapy with PARP inhibitors.
  • are pregnant or nursing